Global In-Vitro Diagnostic Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 153289
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 139
  • list Pharmaceuticals and Healthcare

In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.

Scope of the Report:

Rising fatal diseases such as CVD, CHD, Stroke, Cancer and other heart diseases are driving the global In vitro diagnostic market.

The global In-Vitro Diagnostic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In-Vitro Diagnostic.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the In-Vitro Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In-Vitro Diagnostic market by product type and applications/end industries.

Market Segment by Companies, this report covers

Abbott

Johnson and Johnson

BD

Danaher

Thermo Fisher Scientific

Bio-Rad

Alere

Hologic

KEM-EN-TEC Diagnostics

Medtronic

Omega Diagnostics

Ortho Clinical Diagnostics

Roche

Siemens Healthineers

Sysmex

Atlas Genetics

ELITechGroup

Biomerieux

Werfen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Disposable IVD Devices

Reusable IVD Devices

Market Segment by Applications, can be divided into

Hospitals and Clinics

Diagnostic Center

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 In-Vitro Diagnostic Market Overview

1.1 Product Overview and Scope of In-Vitro Diagnostic

1.2 Classification of In-Vitro Diagnostic by Types

1.2.1 Global In-Vitro Diagnostic Revenue Comparison by Types (2017-2023)

1.2.2 Global In-Vitro Diagnostic Revenue Market Share by Types in 2017

1.2.3 Disposable IVD Devices

1.2.4 Reusable IVD Devices

1.3 Global In-Vitro Diagnostic Market by Application

1.3.1 Global In-Vitro Diagnostic Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Center

1.4 Global In-Vitro Diagnostic Market by Regions

1.4.1 Global In-Vitro Diagnostic Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) In-Vitro Diagnostic Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) In-Vitro Diagnostic Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In-Vitro Diagnostic Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) In-Vitro Diagnostic Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In-Vitro Diagnostic Status and Prospect (2013-2023)

1.5 Global Market Size of In-Vitro Diagnostic (2013-2023)

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 In-Vitro Diagnostic Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson and Johnson

2.2.1 Business Overview

2.2.2 In-Vitro Diagnostic Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson and Johnson In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.3 BD

2.3.1 Business Overview

2.3.2 In-Vitro Diagnostic Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BD In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.4 Danaher

2.4.1 Business Overview

2.4.2 In-Vitro Diagnostic Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Danaher In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.5 Thermo Fisher Scientific

2.5.1 Business Overview

2.5.2 In-Vitro Diagnostic Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Thermo Fisher Scientific In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.6 Bio-Rad

2.6.1 Business Overview

2.6.2 In-Vitro Diagnostic Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bio-Rad In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.7 Alere

2.7.1 Business Overview

2.7.2 In-Vitro Diagnostic Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Alere In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.8 Hologic

2.8.1 Business Overview

2.8.2 In-Vitro Diagnostic Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Hologic In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.9 KEM-EN-TEC Diagnostics

2.9.1 Business Overview

2.9.2 In-Vitro Diagnostic Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.10 Medtronic

2.10.1 Business Overview

2.10.2 In-Vitro Diagnostic Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Medtronic In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.11 Omega Diagnostics

2.11.1 Business Overview

2.11.2 In-Vitro Diagnostic Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Omega Diagnostics In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.12 Ortho Clinical Diagnostics

2.12.1 Business Overview

2.12.2 In-Vitro Diagnostic Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Ortho Clinical Diagnostics In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.13 Roche

2.13.1 Business Overview

2.13.2 In-Vitro Diagnostic Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Roche In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.14 Siemens Healthineers

2.14.1 Business Overview

2.14.2 In-Vitro Diagnostic Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Siemens Healthineers In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.15 Sysmex

2.15.1 Business Overview

2.15.2 In-Vitro Diagnostic Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Sysmex In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.16 Atlas Genetics

2.16.1 Business Overview

2.16.2 In-Vitro Diagnostic Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Atlas Genetics In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.17 ELITechGroup

2.17.1 Business Overview

2.17.2 In-Vitro Diagnostic Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 ELITechGroup In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.18 Biomerieux

2.18.1 Business Overview

2.18.2 In-Vitro Diagnostic Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Biomerieux In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

2.19 Werfen

2.19.1 Business Overview

2.19.2 In-Vitro Diagnostic Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Werfen In-Vitro Diagnostic Revenue, Gross Margin and Market Share (2016-2017)

3 Global In-Vitro Diagnostic Market Competition, by Players

3.1 Global In-Vitro Diagnostic Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 In-Vitro Diagnostic Players Market Share

3.2.2 Top 10 In-Vitro Diagnostic Players Market Share

3.3 Market Competition Trend

4 Global In-Vitro Diagnostic Market Size by Regions

4.1 Global In-Vitro Diagnostic Revenue and Market Share by Regions

4.2 North America In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

4.3 Europe In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

4.5 South America In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

5 North America In-Vitro Diagnostic Revenue by Countries

5.1 North America In-Vitro Diagnostic Revenue by Countries (2013-2018)

5.2 USA In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

5.3 Canada In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

5.4 Mexico In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

6 Europe In-Vitro Diagnostic Revenue by Countries

6.1 Europe In-Vitro Diagnostic Revenue by Countries (2013-2018)

6.2 Germany In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

6.3 UK In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

6.4 France In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

6.5 Russia In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

6.6 Italy In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

7 Asia-Pacific In-Vitro Diagnostic Revenue by Countries

7.1 Asia-Pacific In-Vitro Diagnostic Revenue by Countries (2013-2018)

7.2 China In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

7.3 Japan In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

7.4 Korea In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

7.5 India In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

8 South America In-Vitro Diagnostic Revenue by Countries

8.1 South America In-Vitro Diagnostic Revenue by Countries (2013-2018)

8.2 Brazil In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

8.3 Argentina In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

8.4 Colombia In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue In-Vitro Diagnostic by Countries

9.1 Middle East and Africa In-Vitro Diagnostic Revenue by Countries (2013-2018)

9.2 Saudi Arabia In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

9.3 UAE In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

9.4 Egypt In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

9.5 Nigeria In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

9.6 South Africa In-Vitro Diagnostic Revenue and Growth Rate (2013-2018)

10 Global In-Vitro Diagnostic Market Segment by Type

10.1 Global In-Vitro Diagnostic Revenue and Market Share by Type (2013-2018)

10.2 Global In-Vitro Diagnostic Market Forecast by Type (2018-2023)

10.3 Disposable IVD Devices Revenue Growth Rate (2013-2023)

10.4 Reusable IVD Devices Revenue Growth Rate (2013-2023)

11 Global In-Vitro Diagnostic Market Segment by Application

11.1 Global In-Vitro Diagnostic Revenue Market Share by Application (2013-2018)

11.2 In-Vitro Diagnostic Market Forecast by Application (2018-2023)

11.3 Hospitals and Clinics Revenue Growth (2013-2018)

11.4 Diagnostic Center Revenue Growth (2013-2018)

12 Global In-Vitro Diagnostic Market Size Forecast (2018-2023)

12.1 Global In-Vitro Diagnostic Market Size Forecast (2018-2023)

12.2 Global In-Vitro Diagnostic Market Forecast by Regions (2018-2023)

12.3 North America In-Vitro Diagnostic Revenue Market Forecast (2018-2023)

12.4 Europe In-Vitro Diagnostic Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific In-Vitro Diagnostic Revenue Market Forecast (2018-2023)

12.6 South America In-Vitro Diagnostic Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa In-Vitro Diagnostic Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure In-Vitro Diagnostic Picture

Table Product Specifications of In-Vitro Diagnostic

Table Global In-Vitro Diagnostic and Revenue (Million USD) Market Split by Product Ty

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery